With over 25 years of experience in healthcare leadership, Chermaen Lindberg serves as a Senior Advisor at ZoaDx, driving innovation in diagnostics and clinical research.  She combines strategic foresight with operational expertise to position ZoaDx at the forefront of the industry.


During the COVID-19 pandemic, Chermaen led her team in managing 17 studies that resulted in nine Emergency Use Authorizations, while advancing clinical trials that brought 18 COVID tests and 5 Influenza Combo tests to market. As a co-founder of L3 Healthcare Solutions, she established a clinical trials division to enhance efficiency, quality, and speed for sponsors navigating tight budgets and timelines.


Recognized for her impact, Chermaen has earned awards for marketing innovation and clinical program leadership. A graduate of California State University, San Marcos, with a Bachelor of Science in Business Administration, she is also a certified clinical software designer. Passionate about mentoring talent, Chermaen fosters high-performing teams that deliver results and redefine excellence in healthcare innovation.